Then again, anti-TNF therapy used for the treatment of other autoimmune diseases, such as RA or Crohn’s disease, seems to increase the risk of vasculitis development and, apart from a few successful reports, this type of therapy is not generally proposed for this group of patients [40]. This evidence concerns the gene TNF and rheumatoid arthritis.